Mill Creek Capital Advisors LLC Has $901,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mill Creek Capital Advisors LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 358.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,717 shares of the exchange traded fund’s stock after purchasing an additional 7,596 shares during the period. Mill Creek Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $901,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Resources Management Corp CT ADV grew its position in shares of SPDR S&P Biotech ETF by 30.3% in the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after purchasing an additional 138 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of SPDR S&P Biotech ETF by 8.3% in the second quarter. Bank of Montreal Can now owns 231,432 shares of the exchange traded fund’s stock valued at $21,556,000 after buying an additional 17,749 shares during the period. DRW Securities LLC acquired a new stake in SPDR S&P Biotech ETF during the second quarter worth approximately $1,384,000. AE Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 13.3% in the 2nd quarter. AE Wealth Management LLC now owns 11,184 shares of the exchange traded fund’s stock valued at $1,037,000 after acquiring an additional 1,314 shares in the last quarter. Finally, LHM Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 22.3% during the 2nd quarter. LHM Inc. now owns 45,775 shares of the exchange traded fund’s stock worth $4,244,000 after purchasing an additional 8,361 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 2.4 %

XBI opened at $99.19 on Tuesday. The company has a 50-day simple moving average of $99.01 and a 200 day simple moving average of $93.91. The stock has a market capitalization of $7.56 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.